sc.kundu's picture

Account information

E-mail:
kundu@i3bs.uminho.pt

Profile

Name:
Subhas C. Kundu
Nacionality: 
INDIA
Position: 
Academic & Research Staff

Research Coordinator (Investgador Coordenador)

3Bs Research Group, I3bs-Research Institute on Biomaterials, Biodegradables, biomimetics,  AvePark, University of Minho, Portugal

 

Ciência ID: 
Scopus ID: 
Researcher ID: 
Background: 

Subhas Kundu received his under graduate degree (B.Sc Hons.) in Agricultural Sciences from Visva Bharati University, Santineketan, India, Master degree (M. Sc.) in Genetics and Plant Breeding and PhD in genetics from Banaras Hindu University, Varanasi, India.  Kundu received his post-doctoral training at Institute of Molecular Biology, Moscow; Department of Biology, York University, Canada; Medical University, Lubeck, Germany; Department of Biology & Biochemistry, Brunel University, UK. He was the Founder Head and Full Professor at the Department of Biotechnology, Indian Institute of Technology Kharagpur (IIT), India and a Distinguished Invited Professor at Dankook University, Korea. In his early teaching career, he was An Assistant to a Full Professor and Head of the Department of Life Sciences at Manipur University, Imphal. He taught genetics, cell and molecular biology, and recombinant DNA technology to undergraduates, post-graduates and pre-doctoral students. Kundu joined  as European Research Area Chair at 3Bs Research Group, University of Minho in September 01, 2016 and  later as Research Coordinator since November 02, 2020.

Research Area: 
  • Natural biomaterial matrices 
  • 3D Cell culture
  • 3D cancer models 
  • Drug screening 
  • Bioactive molecule delivery 
Project: 

FoReCaST (http://forecast.3bs.pt/)

Forefront Research in 3D Disease Cancer Models as in vitro Screening Technologies (completed on December 31, 2021)

FCT - BREAST-IT: Adding another brick in the wall: immune system integration in a 3D bioengineered microtumor to investigate immune-competence mechanism in tumor microenvironment. PTDC/BTM-ORG/28168/2017 (completed on June 30, 2022)

Back to top